GAD1 and bipolar disorder: Down-regulated levels of GAD1 mRNA and GAD67 protein are characteristic features of various neurocognitive and psychiatric disorders, including autism, bipolar disorder, epilepsy, and schizophrenia (Akbarian et al. 1995; Volk et al. 2000; Thompson et al. 2009).